Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pueraria lobata polysaccharides are bioactive carbohydrate polymers extracted from the root of *Pueraria lobata* (Kudzu). These polysaccharides are being investigated for their potential therapeutic effects in metabolic disorders, particularly polycystic ovary syndrome (PCOS) and insulin resistance. The mechanism of action is believed to involve the modulation of gut microbiota composition, reduction of systemic inflammation, and improvement of insulin signaling pathways. In clinical research led by Guangzhou Medical University and Guangzhou Women and Children's Medical Center, these polysaccharides are being evaluated as a dietary intervention in overweight and obese women to improve insulin sensitivity, menstrual regularity, and body composition, often studied alongside background metformin therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pueraria lobata polysaccharides.